Literature DB >> 15643671

Dormant hypermethylated tumour suppressor genes: questions and answers.

Manel Esteller1.   

Abstract

The epigenetic inactivation of tumour suppressor genes by promoter CpG island methylation is nowadays one of the hottest topics in cancer research. However, there are still several important open questions: Can we use CpG island hypermethylation to classify tumours according to their clinical behaviour and chemosensitivity? How do we prove that our hypermethylated gene is important for cancer development and/or progression? Which enzymes are directly responsible for the CpG island hypermethylation of tumour suppressor genes? How is the chromatin structure and molecular environment in and around the hypermethylated CpG islands? Can we wake up these dormant hypermethylated tumour suppressor genes in an epigenetic therapy of cancer? Some answers are provided in this review, but other questions remain unsolved, awaiting the eager epigenetic researcher.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643671     DOI: 10.1002/path.1707

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

1.  Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.

Authors:  Lian-He Yang; Hong-Tao Xu; Qing-Chang Li; Gui-Yang Jiang; Xiu-Peng Zhang; Huan-Yu Zhao; Ke Xu; En-Hua Wang
Journal:  Tumour Biol       Date:  2012-11-29

2.  Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma.

Authors:  Hiaki Sato; Takashi Oka; Yoko Shinnou; Takami Kondo; Kana Washio; Masayuki Takano; Katsuyoshi Takata; Toshiaki Morito; Xingang Huang; Maiko Tamura; Yuta Kitamura; Nobuya Ohara; Mamoru Ouchida; Koichi Ohshima; Kenji Shimizu; Mitsune Tanimoto; Kiyoshi Takahashi; Masao Matsuoka; Atae Utsunomiya; Tadashi Yoshino
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

3.  Identification of T-cadherin as a novel target of DNA methyltransferase 3B and its role in the suppression of nerve growth factor-mediated neurite outgrowth in PC12 cells.

Authors:  Shoumei Bai; Kalpana Ghoshal; Samson T Jacob
Journal:  J Biol Chem       Date:  2006-03-14       Impact factor: 5.157

4.  Quantitative methylation profiles for multiple tumor suppressor gene promoters in salivary gland tumors.

Authors:  Megan L Durr; Wojciech K Mydlarz; Chunbo Shao; Marianna L Zahurak; Alice Y Chuang; Mohammad O Hoque; William H Westra; Nanette J Liegeois; Joseph A Califano; David Sidransky; Patrick K Ha
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

5.  Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis.

Authors:  Mercedes Zurita; Pedro C Lara; Rosario del Moral; Blanca Torres; José Luis Linares-Fernández; Sandra Ríos Arrabal; Joaquina Martínez-Galán; Francisco Javier Oliver; José Mariano Ruiz de Almodóvar
Journal:  BMC Cancer       Date:  2010-05-20       Impact factor: 4.430

6.  C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.

Authors:  Jing Lu; Mingxin Wen; Yurong Huang; Xiuquan He; Yunshan Wang; Qi Wu; Zengchun Li; Andres Castellanos-Martin; Mar Abad; Juan J Cruz-Hernandez; Cesar A Rodriguez; Jesús Pérez-Losada; Jian-Hua Mao; Guangwei Wei
Journal:  Epigenetics       Date:  2013-04-26       Impact factor: 4.528

7.  A new dimethyl sulfoxide-based method for gene promoter methylation detection.

Authors:  Natalia Kholod; Jacques Boniver; Philippe Delvenne
Journal:  J Mol Diagn       Date:  2007-10-04       Impact factor: 5.568

8.  Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.

Authors:  Zhaojun Liu; Jun Zhang; Yanhong Gao; Lirong Pei; Jing Zhou; Liankun Gu; Lianhai Zhang; Budong Zhu; Naoko Hattori; Jiafu Ji; Yasuhito Yuasa; Wooho Kim; Toshikazu Ushijima; Huidong Shi; Dajun Deng
Journal:  Clin Cancer Res       Date:  2014-07-09       Impact factor: 12.531

Review 9.  Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos?

Authors:  Vanesa C Sanchez; Jodie R Pietruska; Nathan R Miselis; Robert H Hurt; Agnes B Kane
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Sep-Oct

10.  ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.

Authors:  Silke Götze; Valeska Feldhaus; Thilo Traska; Marietta Wolter; Guido Reifenberger; Andrea Tannapfel; Cornelius Kuhnen; Dirk Martin; Oliver Müller; Sonja Sievers
Journal:  BMC Cancer       Date:  2009-12-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.